Cancer-causing chemical levels in Coke sold abroad remain excessive, U.S. group says

By J. D. Heyes

After narrowly escaping a federal claim of false advertising with a "pomegranate" drink that contained a barely legal amount of pomegranate juice, now Coca-Cola faces a new issue: cancer-causing ingredients in its namesake beverage.

According to a recent report from the Center for Science in the Public Interest, a U.S. watchdog organization, the version of Coke sold in several countries, including Kenya and Brazil, still contains an elevated level of a chemical that has been linked to cancer in animals - months after the beverage giant made changes to Coca-Cola sold in the state of California.

The group said samples of the soft drink were tested in nine countries, and each showed "alarming amounts" of the chemical 4-methylimidazole, or 4-MI, which is used in the soda's caramel coloring. The group said high levels of 4-MI have been linked to cancer in some animals.

In March Coca-Cola, along with beverage rival PepsiCo, said the companies had requested that suppliers of their caramel coloring change their manufacturing process to fall in line with a ballot initiative in California that sought to limit the public's exposure to toxic chemicals, Reuters reported. Read more...

Ayurtox for Body Detoxification

Researchers Perfect the View of Heart Disease

(HealthDay News) -- Radiologists have developed a way to gain better insight into signs of heart disease by using cardiac CT scans that detect narrowed arteries and low blood flow.

CT scans use X-rays to create cross-sectional images of the body's internal anatomy. The scans can detect blockages in coronary arteries, but it's hard to tell if they're actually preventing blood from flowing to the heart.

In a new study, published Sept. 15 in the Journal of the American College of Cardiology, researchers at Massachusetts General Hospital explained how to gain more detailed pictures of what is going on inside the body, potentially giving doctors more information about the best treatment.

The research, based on tests in 34 cardiac patients, "is among the first demonstrations of the use of cardiac CT to detect both coronary artery stenosis and resulting myocardial ischemia simultaneously in a single examination," Dr. Ricardo C. Cury, a cardiac imaging specialist at the hospital's Heart Center and the study's principal investigator, explained in a hospital news release. Read more…

Cardiofy Heart Care Supplement

Woman disabled by antibiotic taken for a simple chest infection

by: D Holt

A patient suffering from a chest infection, and given antibiotics, claims she is now incapacitated due to the side effects of the drug that should have cured her condition. Within three days of being prescribed ciprofloxacin the housewife complained of extreme tightness in the back of her calf muscles and could barely walk. Ten days later she was rushed to hospital after a sharp pain in her left calf and was treated for a ruptured Achilles tendon. The patient, Judy Thomas from Devon, claims she has been unable to walk properly since and is now terrified the right tendon will rupture as it also showed signs of severe damage. Read more…

Cardiofy Heart Care Supplement

Another Blood Fat Fuels Heart Attack Risk

(HealthDay News) -- Yet another type of blood fat may be linked to higher cardiac risk, a new study suggests.

A Danish study finds an increased risk of heart attacks in people whose genes give them high blood levels of a cholesterol-related blood fat, lipoprotein(a), but the researchers say more work is needed to justify treatment to reduce those levels.

"We show that those with the 10 percent highest lipoprotein(a) have a two- to threefold increased risk of myocardial infarction [heart attack], similar to that for the highest LDL cholesterol levels," said Dr. Borge G. Nordestgaard, a professor of clinical biochemistry at Copenhagen University, and lead author of a report in the June 10 issue of the Journal of the American Medical Association.

However, a large-scale trial is needed to tell whether drugs aimed at reducing lipoprotein(a) (LPA) levels would lower the risk, Nordestgaard said. One compound, niacin, also known as nicotinic acid or vitamin B3, is known to reduce LPA levels, he said.

"I am not aware of other drugs being developed to lower lipoprotein(a), but I certainly hope that our study will make big pharmaceutical companies interested in developing such drugs," Nordestgaard said. Read more… 

Cardiofy Heart Care Supplement

Effect of invasive coronary revascularization in acute MI

Below is a review of a new study supporting BYPASS SURGERY in dramatically lowering death rates. Does this new study in AM J of Cardiology force you to refer your CV patients for surgery? Does this require you to alter your INFORMED CONSENT procedures in case a patient that you treat later dies?

I have MY answers but if something ever goes wrong you need your answers on the tip of your tongue. It is not enough to know the right answer by the time things are in court. You need to have dissected this WEAK study enough to know why you are not suddenly required to push surgery to patients who consult with you about their CAD problems

This major 5 years Canadian study of revascularization surgery during hospitalization for acute MI is done by University of Alberta and in a current AM J of Cardiology. The death rate in this study was ONLY 5% in the operated group vs. 17% in those not receiving surgery. So what does that prove? To me that is a bad outcome in both studies because they are both wrong in their approach. I am convinced that lowering blood viscosity safely with Beyond Chelation Improved is the correct approach. Read more…

Cardiofy Heart Care Supplement